Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Heart Valve Diseases » Aortic Valve Disease » Aortic Valve Stenosis » Aortic Stenosis, Subvalvular » Cardiomyopathy, Hypertrophic » Cardiomyopathy, Hypertrophic, Familial
Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Cardiomyopathies » Cardiomyopathy, Hypertrophic » Cardiomyopathy, Hypertrophic, Familial
Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Genetic Diseases, Inborn » Cardiomyopathy, Hypertrophic, Familial
Description
An autosomal dominant inherited form of HYPERTROPHIC CARDIOMYOPATHY. It results from any of more than 50 mutations involving genes encoding contractile proteins such as VENTRICULAR MYOSINS; cardiac TROPONIN T; ALPHA-TROPOMYOSIN. MeSH
Hierarchy View
Approved Indicated Drugs (1)
Phase 2 Indicated Drugs (1)
Organization Involved with Phase 2 Indications (1)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.